(1R,2S)-1-tert-Butoxycarbonylamino-2-vinylcyclopropanecarboxylic acid

We are (1R,2S)-1-tert-Butoxycarbonylamino-2-vinylcyclopropanecarboxylic acid CAS:159622-10-3 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:(1R,2S)-1-tert-Butoxycarbonylamino-2-vinylcyclopropanecarboxylic acid
CAS.NO:159622-10-3
Synonyms:(1R,2S)-1-tert-Butoxycarbonylamino-2-vinylcyclopropanecarboxylic acid
(1R,2S)-1-(tert-butoxycarbonylamino)-2-vinylcyclopropanecarboxylic acid
(1R,2S)-2-ethenyl-1-[(2-methylpropan-2-yl)oxycarbonylamino]cyclopropane-1-carboxylic acid
(1R,2S)-1-[(tert-butoxycarbonyl)amino]-2-ethenylcyclopropanecarboxylic acid
(1R,2S)-1-({[(2-Methyl-2-propanyl)oxy]carbonyl}amino)-2-vinylcyclopropanecarboxylic acid
(1R,2S)-1-[(tert-butoxycarbonyl)amino]-2-vinylcyclopropanecarboxylic acid
 
Physical and Chemical Properties:
Density 1.2±0.1 g/cm3
Boiling Point 361.0±42.0 °C at 760 mmHg
Molecular Formula C11H17NO4
Molecular Weight 227.257
Flash Point 172.1±27.9 °C
Vapour Pressure 0.0±1.7 mmHg at 25°C
Index of Refraction 1.508
 
Specification:
Appearance:White powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Asunaprevir(CAS:630420-16-5).

(1R,2S)-1-tert-Butoxycarbonylamino-2-vinylcyclopropanecarboxylic acid


Related News: “No two studies are the same, and each carries its own unique risks and presents individual challenges, but the aim of CTSuccess is to use the experience we have as a company in supplying materials for thousands of trials to identify the characteristics of a project upfront and highlight potential risk factors that may arise,” said Kristen Devito, Global Director, Catalent Clinical Supply Services.N, N-difenilimidazol-1-carboxamida CAS:2875-79-8 In August, the Company announced that the U.S. Patent and Trademark Office issued U.S. Patent No. 10,370,452 covering compositions and uses of effector T cells expressing a CAR, where such T cells are derived from a pluripotent stem cell, including an iPSC.403-24-7 Oligomannate, which uses extract from marine brown algae as raw material, received a conditional green light to treat mild-to-moderate level AD, the National Medical Products Administration (NMPA) said in a statement on its website late on Saturday.1,1-Cyclohexane Diacetic Anhydride By drawing these distinctions between APIs and the drugs themselves, manufacturers are able to specialize and pharmacists able to align generic equivalents with brand names.Onconova is currently in the clinical development stage with oral and IV rigosertib, including clinical trials studying single agent IV rigosertib in second-line higher-risk MDS patients (pivotal Phase 3 INSPIRE trial) and oral rigosertib plus azacitidine in first-line and refractory higher-risk MDS patients (Phase 2).

Related Products
Product Name
isonicotinic acid View Details
3-Aminophenylacetylene View Details
Quinoline-2,3-dicarboxylic acid View Details
(1R,2R)-(-)-1,2-Cyclohexanedicarboxylic Acid manufacturer 2,4,5-Trichloropyrimidine manufacturer 4-hydroxycoumarin manufacturer 2-Chloro-3-amino-4-methyl pyridine manufacturer Dimethylcarbamoyl chloride manufacturer